(Reuters) -U.S. Health Secretary Robert F. Kennedy Jr.'s surprise ouster of a national vaccine advisory board, claiming it ...

Ng reported personal fees from Bayer, Pfizer, CytomX, Jazz Pharmaceuticals, Revolution Medicines, Agenus, Johnson & Johnson, ...

Efimosfermin is a long-acting engineered variant of FGF21 designed to have a prolonged half-life, the authors noted, and has ...

CHICAGO — Acute lymphoblastic leukemia (ALL) remains challenging to treat in older adult patients due to biological factors ...

New findings suggest that a PSA level of 0.2 ng/mL or greater can predict a poor prognosis and indicate a possible need for ...

The dividend remains well supported -- the REIT reported funds from operations ( FFO) per share of $1.05 during the first ...

Dividend stocks can set you up for life. But, making the right choice will determine whether you enjoy a steady income or ...

Novavax's COVID-19-influenza vaccines show strong immune response in older adults, paving the way for regulatory approval.

Some appointees hold some of Kennedy’s more critical views on vaccines, while other picks appear to be olive branches to ...

The ISG State of the Agentic AI Market report findings will be presented at the ISG AI Impact Summit, June 23–24 at the ...

German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion worth of BioNTech shares, it ...

The president wants a the most-favored-nation pricing model. But the U.S. drug industry is offering a host of reasons why ...